Verve Therapeutics Inc.

6.18
-0.15 (-2.37%)
At close: Mar 03, 2025, 3:59 PM
6.15
-0.57%
After-hours: Mar 03, 2025, 04:27 PM EST

Verve Therapeutics Ratios Statement

Year FY24 FY23 FY22 FY21 FY20 FY19
PE Ratio -2.39 -4.47 -6.64 -15.08 -33.79 -80.92
PEG Ratio 0.10 -0.62 -0.35 -0.09 -0.24 n/a
PS Ratio 14.69 76.08 538.57 n/a n/a n/a
PB Ratio 0.96 1.49 1.90 5.01 -24.08 -78.71
P/FCF Ratio -2.94 -5.63 -7.71 -21.75 -39.78 -165.51
P/OCF Ratio -3.01 -5.98 -8.55 -22.97 -43.64 -206.81
OCF/S Ratio -4.88 -12.72 -63.03 n/a n/a n/a
Debt / Equity Ratio 0.14 0.12 0.15 0.01 -1.96 -1.79
Quick Ratio 12.65 17.24 16.05 16.67 10.11 5.36
Current Ratio 12.65 17.24 16.05 16.67 10.11 5.36
Asset Turnover 0.05 0.02 0.00 n/a n/a n/a
Interest Coverage n/a n/a n/a n/a n/a n/a
Return on Equity (ROE) -0.4 -0.33 -0.29 -0.33 0.71 0.97
Return on Assets (ROA) -0.31 -0.27 -0.23 -0.31 -0.58 -0.88
Return on Capital (ROIC) -0.38 -0.31 -0.26 -0.24 -0.57 -0.75
Dividend Yield n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a
Gross Profit Margin 100.00% 53.61% -245.75% n/a n/a n/a
Net Profit Margin -614.59% -1.7K% -8.11K% n/a n/a n/a
Pretax Profit Margin -613.51% -1.7K% -8.11K% n/a n/a n/a
Operating Profit Margin -707.23% -1.9K% -8.54K% n/a n/a n/a
FCF Margin -499.28% -1.35K% -6.98K% n/a n/a n/a
EBITDA Margin -707.23% -1.85K% -8.39K% n/a n/a n/a